Raised creatinine or low eGFR found (acute or chronic?)
BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.
Recent rapid rise, oliguria or severity sign: advice the same day
- Refer to the emergency department or the nephrologist the same day; enclose previous serum creatinine results and the list of medicines.
- Rise ≥ 26.5 µmol/L in 48 h or × 1.5 in 7 days, collapsed urine output, hyperkalaemia, glomerular syndrome (haematuria, proteinuria, hypertension) or extrarenal signs.
- Urine dipstick (in the practice, as soon as AKI is suspected)
Found in a stable patient: recheck, date it, look for the cause
Laboratory tests
- Serum creatinine with eGFR (CKD-EPI), repeat
- Serum electrolytes (potassium)
- Urea (if acute kidney injury suspected)if neededRecent rise in creatinine compared with previous values (possible AKI): urea is part of the laboratory work-up of AKI [2]; its NABM coverage is limited to AKI, CKD (nutritional assessment) and dialysis [8].
- FBC (if acute kidney injury suspected)if needednon-French guidelineRecent rise in creatinine: the full blood count with differential is part of the AKI work-up and points to thrombotic microangiopathy or vasculitis [2].
Urine tests
- Urine albumin:creatinine ratio (ACR), spot sample, preferably first morning urine
- Urine dipstick (in the practice)
- Urine microscopy and culture with quantitative cytology (if dipstick positive for blood or leucocytes)if neededDipstick positive for blood or leucocytes: haematuria (> 10 RBC/mm³ after ruling out a urological cause) or leucocyturia (> 10 WBC/mm³ without infection) are markers of renal involvement [1].
- Take the serum creatinine sample at a distance (at least 12 hours) from a meal of cooked meat or fish and without creatine supplements.
- Renal and bladder ultrasound (obstruction, size and appearance of the kidneys).
Do not order
- 24-hour creatinine clearance and the Cockcroft–Gault formula: the HAS asks that Cockcroft–Gault no longer be used to adjust doses (it underestimates GFR with standardised creatinine measurement), and measured clearance does not faithfully reflect glomerular filtration, notably when GFR falls [1].
Sources (8)
- Haute Autorité de santé. Guide du parcours de soins – Maladie rénale chronique de l'adulte (MRC). Validé en juillet 2021, mis à jour en septembre 2023.
- Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1-138.
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117-S314.
- National Institute for Health and Care Excellence (NICE). Acute kidney injury: prevention, detection and management. NICE guideline NG148, publiée le 18 décembre 2019, mise à jour le 16 octobre 2024.
- Mercado MG, Smith DK, Guard EL. Acute kidney injury: diagnosis and management. Am Fam Physician. 2019;100(11):687-694.
- Kidney Health Australia. Chronic Kidney Disease (CKD) Management in Primary Care. 5e édition. Melbourne : Kidney Health Australia ; 2024 (manuel destiné à la médecine générale).
- National Institute for Health and Care Excellence (NICE). Chronic kidney disease: assessment and management. NICE guideline NG203, publiée le 25 août 2021, mise à jour le 24 novembre 2021 (recommandations 1.1.4, 1.1.6, 1.1.8, 1.1.16, 1.1.25 et 1.3.6, et justification sur la cystatine C).
- Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : acte 0591 (urée) ; absence d'acte de cystatine C.